Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index; none of the 86 sources its claims cite is checked for support yet.

Marijuana Use in Pregnancy and While Breastfeeding

Open access
Metz, Torri D., Borgelt, Laura M.·2018·Obstetrics & Gynecology

Abstract

The prevalence and perceived safety of marijuana use in pregnancy are increasing with expanding legalization. Marijuana crosses the placenta and passes into breast milk, resulting in fetal and neonatal exposure. Many women cite medical reasons for prenatal marijuana use such as nausea and vomiting of pregnancy, anxiety, and chronic pain. The scientific literature regarding marijuana in pregnancy is mixed, resulting in confusion among practitioners as to how to counsel women about risks of use. In addition, there is a paucity of literature related to marijuana use and breastfeeding. Existing pregnancy studies are predominantly retrospective cohorts with a reliance on self-report for ascertainment of exposure, which underestimates use. Many studies fail to adjust for important confounding factors such as tobacco use and sociodemographic differences. Despite the limitations of the existing evidence, there are animal and human data suggesting potential harm of cannabis use. The harms are biologically plausible given the role of the endocannabinoid system in pregnancy implantation, placentation, and fetal neurologic development. Two recent systematic reviews and meta-analyses found an association between marijuana use and adverse perinatal outcomes, especially with heavy marijuana use. In addition, three longitudinal cohort studies demonstrate a possible effect of prenatal marijuana exposure on long-term neurobehavioral outcomes. Marijuana use may be associated with growth restriction, stillbirth, spontaneous preterm birth, and neonatal intensive care unit admission. Therefore, women should be advised to refrain from using marijuana during pregnancy and lactation.

Overview

CoChat Summary

TL;DR

This narrative review summarizes evidence on prenatal and lactation marijuana exposure, noting rising prevalence and perceived safety despite mixed literature. It concludes that women should be advised to refrain from marijuana during pregnancy and breastfeeding because of biologically plausible and observed risks, especially with heavy use.

Key findings

  • Self-reported prenatal marijuana use rose from 2.37% (95% CI 1.85–3.04) in 2002 to 3.85% (95% CI 2.87–5.18) in 2014; in a Kaiser population with universal urine toxicology in 2016, use was 7.1% (95% CI 6.7–7.5%), and over half of users were identified only by toxicology.
  • Gunn et al. found associations with anemia (pooled OR 1.36, 95% CI 1.10–1.69), low birth weight <2500 g (pooled OR 1.77, 95% CI 1.04–3.01; mean pooled birthweight difference 109 g), and NICU admission (pooled OR 2.02, 95% CI 1.27–3.21), but not preterm birth (pooled OR 1.29, 95% CI 0.80–2.08).
  • Conner et al. found no association between any marijuana use and low birth weight (adjusted pooled RR 1.16, 95% CI 0.98–1.37) or preterm birth (adjusted pooled RR 1.08, 95% CI 0.82–1.43) after adjustment for confounders, but moderate-to-heavy use was associated with low birth weight (RR 1.90, 95% CI 1.44–2.45) and preterm birth (RR 2.04, 95% CI 1.32–3.17).
  • Marijuana crosses the placenta and passes into breastmilk; one study estimated delta-9-THC in pumped breastmilk at a mean of 2.5% (range 0.4%–8.7%) of the maternal dose, with average absolute infant dose estimated at 8 micrograms/kg/day. Stillbirth was associated with marijuana use (pooled OR 1.74, 95% CI 1.03–2.93) and with cord homogenate THC metabolites (OR 2.34, 95% CI 1.13–4.81).

Methods

  • Narrative review of human and animal literature on marijuana use in pregnancy and breastfeeding, including pharmacology, endocannabinoid biology, and clinical outcomes.
  • The authors did not perform a new meta-analysis; they relied on two recent systematic reviews and meta-analyses (Gunn et al. and Conner et al.), the 2017 National Academy of Sciences consensus report, longitudinal cohort studies, and other observational studies.
  • Main analysis is a qualitative synthesis of prevalence, perceived safety, therapeutic uses, pregnancy outcomes, breastfeeding data, and counseling recommendations.

Limitations

  • Stated: existing pregnancy studies are predominantly retrospective cohorts, rely on self-report which underestimates use, often fail to adjust for important confounders such as tobacco use and sociodemographic differences, and there is a paucity of literature on breastfeeding.
  • Stated: heterogeneity of findings limits certainty; longitudinal neurobehavioral studies have difficulty controlling for childhood environment, and may not reflect contemporary products with higher delta-9-THC concentrations.
  • Evident: as a narrative review without new meta-analysis, conclusions depend on the included studies’ designs and cannot resolve the mixed findings; the authors also note insufficient evidence for congenital anomalies and long-term childhood outcomes.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1097/aog.0000000000002878

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 Valid · 1 Not valid · 80 Not checked · 23 Own results and interpretations

65 more claims

Create a free account to see all 104 claims and to verify the 78 references still open.

See all claims — free account
  • It may state two separate claims as one. 23
  • Probably not a substantial claim. 15

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 57 references

Cited by

See all 185

Metadata

Authors
Metz, T. D., & Borgelt, L. M.
Affiliations
Denver Health Medical Center (US)
Venue
Obstetrics & Gynecology
Published
2018-11
Volume
132
Issue
5
Pages
1198-1210
ISSN
  • 0029-7844 (ISSN-L)
  • 1873-233X
OpenAlex
W2894899239
Cited by
185
References
57
Citations by year
2026: 9 · 2025: 18 · 2024: 27 · 2023: 23 · 2022: 33 · 2021: 30 · 2020: 25 · 2019: 17 · 2018: 1
FWCI
3.18
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Obstetrics and Gynecology (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12HD001271)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
  • Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
Keywords
cannabis use, cannabis use during pregnancy, breastfeeding, prenatal exposure, placental transfer, endocannabinoid system, perinatal outcomes, fetal brain development, growth restriction, preterm birth, stillbirth, neonatal intensive care, medical cannabis, patient counseling
MeSH terms
Congenital Abnormalities, Marijuana Use, Animals, Breast Feeding, Cannabinoids, Female, Humans, Infant, Low Birth Weight, Infant, Newborn, Intensive Care Units, Neonatal, Pregnancy, Directive Counseling, Fetal Development, Premature Birth, Stillbirth, Endocannabinoids, Medical Marijuana

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Marijuana Use in Pregnancy and While Breastfeeding. https://app.cochat.ai/papers/10.1097/aog.0000000000002878
The paper
Metz, T. D., & Borgelt, L. M. (2018). Marijuana Use in Pregnancy and While Breastfeeding. Obstetrics & Gynecology. https://doi.org/10.1097/aog.0000000000002878

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.